Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M414273200 on January 14, 2005

J. Biol. Chem., Vol. 280, Issue 13, 12810-12819, April 1, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/13/12810    most recent
M414273200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawar, Z. S.
Right arrow Articles by Cummings, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawar, Z. S.
Right arrow Articles by Cummings, R. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Novel Poly-GalNAc{beta}1–4GlcNAc (LacdiNAc) and Fucosylated Poly-LacdiNAc N-Glycans from Mammalian Cells Expressing {beta}1,4-N-Acetylgalactosaminyltransferase and {alpha}1,3-Fucosyltransferase*

Ziad S. Kawar{ddagger}, Stuart M. Haslam§, Howard R. Morris¶, Anne Dell§||, and Richard D. Cummings{ddagger}**

From the {ddagger}Department of Biochemistry and Molecular Biology, Oklahoma Center for Medical Glycobiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, the §Department of Biological Sciences, Imperial College London, London SW7 2AZ, United Kingdom, and M-SCAN Mass Spectrometry Research and Training Centre, Silwood Park, Ascot SL5 7PZ, United Kingdom

Glycans containing the GalNAc{beta}1–4GlcNAc (LacdiNAc or LDN) motif are expressed by many invertebrates, but this motif also occurs in vertebrates and is found on several mammalian glycoprotein hormones. This motif contrasts with the more commonly occurring Gal{beta}1–4GlcNAc (LacNAc or LN) motif. To better understand LDN biosynthesis and regulation, we stably expressed the cDNA encoding the Caenorhabditis elegans {beta}1,4-N-acetylgalactosaminyltransferase (GalNAcT), which generates LDN in vitro, in Chinese hamster ovary (CHO) Lec8 cells, to establish L8-GalNAcT CHO cells. The glycan structures from these cells were determined by mass spectrometry and linkage analysis. The L8-GalNAcT cell line produces complex-type N-glycans quantitatively bearing LDN structures on their antennae. Unexpectedly, most of these complex-type N-glycans contain novel "poly-LDN" structures consisting of repeating LDN motifs (-3GalNAc{beta}1–4GlcNAc{beta}1-)n. These novel structures are in contrast to the well known poly-LN structures consisting of repeating LN motifs (-3Gal{beta}1–4GlcNAc{beta}1-)n. We also stably expressed human {alpha}1,3-fucosyltransferase IX in the L8-GalNAcT cells to establish a new cell line, L8-GalNAcT-FucT. These cells produce complex-type N-glycans with {alpha}1,3-fucosylated LDN (LDNF) GalNAc{beta}1–4(Fuc{alpha}1–3)GlcNAc{beta}1-R as well as novel "poly-LDNF" structures (-3GalNAc{beta}1–4(Fuc{alpha} 1–3)GlcNAc{beta}1-)n. The ability of these cell lines to generate glycoprotein hormones with LDN-containing N-glycans was studied by expressing a recombinant form of the common {alpha}-subunit in L8-GalNAcT cells. The {alpha}-subunit N-glycans carried LDN structures, which were further modified by co-expression of the human GalNAc 4-sulfotransferase I, which generates SO4-4GalNAc{beta}1–4GlcNAc-R. Thus, the generation of these stable mammalian cells will facilitate future studies on the biological activities and properties of LDN-related structures in glycoproteins.


Received for publication, December 20, 2004 , and in revised form, January 14, 2005.

* This work was supported by National Institutes of Health Grant RO1 CH/HD54832-01 (to R. D. C.) and by the Biotechnology and Biological Sciences Research Council and the Wellcome Trust (to A. D. and H. R. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| A Biotechnology and Biological Sciences Research Council Professorial Fellow.

** To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, OK Center for Medical Glycobiology, University of Oklahoma Health Sciences Center, 975 N.E. 10th St., BRC Rm. 417, Oklahoma City, OK 73104. Tel.: 405-271-2481; Fax: 405-271-3910; E-mail: richard-cummings{at}ouhsc.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
GlycobiologyHome page
S. K. Patnaik, B. Potvin, S. Carlsson, D. Sturm, H. Leffler, and P. Stanley
Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells
Glycobiology, April 1, 2006; 16(4): 305 - 317.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement